• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiology of paediatric Middle East respiratory syndrome coronavirus and implications for the control of coronavirus virus disease 2019

Shiloh

Editor, Senior Moderator
Source: https://onlinelibrary.wiley.com/doi/10.1111/jpc.15014

Epidemiology of paediatric Middle East respiratory syndrome coronavirus and implications for the control of coronavirus virus disease 2019
Chandini R MacIntyre; Xin Chen; Dillon C Adam; Abrar A Chughtai
First published: 30 July 2020
https://doi.org/10.1111/jpc.15014

Aim

To compare the clinical features of Middle East respiratory syndrome coronavirus (MERS‐CoV) infection between paediatric and adult cases.
Methods

Using multiple public data sources, we created an enhanced open‐source surveillance dataset of all MERS‐CoV cases between 20 September 2012 and 31 December 2018 in Saudi Arabia including available risk factor data.
Results

Of the 1791 cases of MERS‐CoV identified, 30 cases (1.7%) were aged under 18 years and 1725 cases (96.3%) were aged 18 years and over. Three paediatric cases were fatal, aged 0, 2 and 15 years. The odds of asymptomatic MERS‐CoV infection among cases under 18 years (n = 10/23; 44%) was significantly higher (odds ratio (OR) = 4.98; 95% confidence interval (CI): 2.15–11.51; P = 0.001) compared to adults (n = 199/1487; 13%). The odds of hospitalisation were significantly lower (OR = 0.17; 95% CI: 0.08–0.39; P < 0.001) among cases under 18 years (n = 12/24; 50%) compared to adults (n = 1231/1443; 85%). Children were more likely to have a known source of exposure compared to adults (OR = 2.68; 95% CI: 1.29–5.56; P = 0.008).

Conclusions

Clinically severe illness is less common in children, although death can occur, and the proportion of paediatric cases (1.7%) is similar to that reported for COVID‐19. Age‐specific differences in the clinical presentation of MERS‐CoV cases could have implications for transmission for other betacoronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Children may be at risk within the household with an infected adult. More studies are required on the role of children in transmission of betacoronaviruses.
 
Back
Top Bottom